Nordicus Partners Corporation (NORD) is a Professional Services company listed on NASDAQ. In the last 30 days Quantisnow tracked 4 wire items for NORD, including 2 SEC filings and 2 insider trades. The most recent was published Nov 11, 2026.
Financial highlights
Full financials- Net income, TTM
- -$5.07M
- Cash
- $5.8K
For the twelve months ended Jun 30, 2026, from SEC filings. Not investment advice.
News · 26 weeks4+100%
2026-05-172026-11-08
Mix490d
- SEC Filings2(50%)
- Insider2(50%)
Activity · 52 weeks43 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
4 items- INSIDERChief Financial Officer Yankowitz Bennett J. was granted 1,000,000 stock options (SEC Form 4)4 - Nordicus Partners Corp (0001011060) (Issuer)
- INSIDERChief Executive Officer Rouf Henrik was granted 2,000,000 stock options (SEC Form 4)4 - Nordicus Partners Corp (0001011060) (Issuer)
- SECNordicus Partners Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits8-K - Nordicus Partners Corp (0001011060) (Filer)
- SECNordicus Partners Corporation filed SEC Form 8-K: Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Nordicus Partners Corp (0001011060) (Filer)
NORD FAQ
8 questionsWhat does Nordicus Partners Corporation do?
Nordicus Partners Corporation is a U.S. based company focusing on acquiring and developing drugs from innovative biotech companies in the Nordics, a region known for its brilliant scientists, exceptional life science ecosystem and drug discoveries and developments. Nordicus is dedicated to developing breakthrough therapeutics in diseases with unmet medical needs - starting with oral disorders. Its scientific foundation targets inflammation and immune modulation. In 2024, Nordicus acquired 100% of Orocidin A/S, a Danish preclinical-stage biotech company developing next-generation therapies for...What is the latest news on NORD?
In the last 30 days Quantisnow tracked 4 wire items for NORD: 2 SEC filings and 2 insider trades. The most recent was published on November 11, 2026.Is NORD profitable?
No. Nordicus Partners Corporation reported a net loss of $5.07M for the twelve months ended Jun 30, 2026.How much cash and debt does NORD have?
Nordicus Partners Corporation reported $5.8K in cash and cash equivalents on its most recent balance sheet in SEC filings.Where does NORD stock trade?
Nordicus Partners Corporation (NORD) is listed on NASDAQ.What sector and industry is NORD in?
Nordicus Partners Corporation operates in the Consumer Discretionary sector, Professional Services industry.What companies are similar to NORD?
Notable peers in the same industry include MAN (ManpowerGroup), FCN (FTI Consulting Inc.), EXPO (Exponent Inc.), G (Genpact Limited), RHI (Robert Half Inc.). Compare NORD side-by-side with any of them on Quantisnow.How can I track NORD on Quantisnow?
Quantisnow aggregates Nordicus Partners Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NORD to receive live email and push alerts on every new disclosure.